Contact Us
CDMO Vendor Selection Qualification & Oversight

Choose the right CDMO and keep manufacturing on track and compliant

BioBoston helps life science teams select, qualify, and oversee CDMOs so you reduce delays, prevent quality surprises, and maintain cGMP compliance across the product lifecycle.

Free Consultation
Call Us
  • Senior QA/RA and cGMP expertise
  • CDMO qualification audits and oversight
  • Global support: on-site or remote

  • Practical, execution-focused support

Who this is for

This service is a fit if

  • You need to select a new CDMO for drug substance or drug product manufacturing
  • You’re preparing for a key milestone (IND/CTA, Phase changes, launch readiness)
  • You’ve experienced CDMO delays, deviations, investigations, or communication gaps
  • You need stronger quality oversight without adding internal headcount
  • You want a defensible vendor file that stands up in audits and inspections

What you’ll get

  • You will receive a clear, regulator-friendly CDMO package:
  • CDMO shortlist aligned to your product, process, and timeline
  • Selection criteria and decision matrix (clear rationale and documentation)
  • Qualification plan based on risk (what to audit, when, and how deep)
  • CDMO audit report and prioritized gap list
  • Contract and quality agreement support (roles, responsibilities, deliverables)
  • Ongoing oversight option with KPIs, escalation pathway, and monthly reporting CAPA support if issues arise (root cause, actions, effectiveness checks)

What we do

Our CDMO Selection, Qualification & Oversight support can include:

  • CDMO identification and screening (technical fit, capacity, compliance history)

  • Selection tailored to your process (sterile/aseptic, biologics, small molecule, etc.)

  • Qualification audits (QMS, batch records, deviations/CAPA, change control, data integrity)

  • Risk assessment and mitigation plan (quality, timelines, supply continuity)

  • Contracting support (SOWs, deliverables, acceptance criteria, governance)

  • Quality agreement support (clear oversight model and responsibilities)

  • Ongoing performance monitoring (KPIs, meeting cadence, issue tracking)

  • CAPA and remediation support for quality events and recurring problems

Why BioBoston

  • CDMO relationships fail when expectations are unclear and oversight is weak.

  •  We bring senior manufacturing-quality experience to prevent the common breakdowns: scope gaps, hidden compliance risks, slow deviation/CAPA cycles, and timeline drift.

  • We help you build a controlled partnership where responsibilities are clear, decisions are documented, and issues are handled early before they become regulatory problems.

Shortlist + qualification plan

We identify the best-fit CDMOs and define the qualification approach based on risk and stage.

Select + control performance

We support contracting, launch oversight, and ongoing performance monitoring to keep the CDMO aligned.

Discovery call

We confirm your product, process, timeline, and the risks you want to avoid.

How it works

Frequently Asked Questions

 Yes. We match the right lead based on your modality and manufacturing needs.

 Yes. We can assess the current setup, close gaps, and implement a practical oversight model.

Yes. We can support global audits depending on site location and scope.

De-risk your CDMO partnership before it impacts your timeline

Free Consultation
Call Us